SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 29 of 51
Word Count: 1414
Character Count: 8833

Document Content:

Waiver. Subject to any non-conflicting terms of the warrant agency agreement and the exercise adjustment provisions of the warrants, the warrants may be modified or amended or the provisions thereof waived (i) with respect to an amendment or modification, upon obtaining the written consent of the Company and the holders of at least 50.1% of the shares common stock issuable upon the exercise of the then-outstanding warrants issued pursuant to the warrant agency agreement and (ii) in the case of a waiver, by the party against whom enforcement of any such waived provision is sought; provided, that, in each case, if any amendment, modification or waiver disproportionately, materially and adversely impacts a warrant holder (or group of holders), the written consent of such disproportionately impacted holder (or group of holders) shall also be required, and provided further that such modification, amendment or waiver applies to all of the then-outstanding warrants.

Warrant Agent; Global Certificate.
The warrants will be issued in registered form under a warrant agent agreement between the Warrant Agent and us. We have applied to list
the warrants on Nasdaq, under the symbol “DUKRW,” and, if approved, trading of the warrants is expected to commence on or
about the date of issuance. The warrants shall initially be represented only by one or more global warrants deposited with the Warrant
Agent, as custodian on behalf of The Depository Trust Company (DTC) and registered in the name of Cede & Co., a nominee of DTC, or
as otherwise directed by DTC.

Fundamental Transactions.
In the event of a fundamental transaction, as described in the warrants and generally including any reorganization, recapitalization or
reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets,
our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common stock, or any person
or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, the holders of the warrants
will be entitled to receive the kind and amount of securities, cash or other property that the holders would have received had they exercised
the warrants immediately prior to such fundamental transaction.

Rights as a Stockholder.
The warrant holders do not have the rights or privileges of holders of common stock or any voting rights until they exercise their warrants
and receive shares of common stock. After the issuance of shares of common stock upon exercise of the warrants, each holder will be entitled
to one vote for each share held of record on all matters to be voted on by stockholders.

Governing Law. The
warrants and the warrant agent agreement are governed by New York law.

Representative’s
Warrants. The registration statement of which this prospectus is a part also
registers for sale the Representative’s Warrants, as a portion of the underwriting compensation payable to the Representative in
connection with this offering. The Representative’s Warrants will be exercisable six months after the effective date of the registration
statement of which this prospectus is a part, will expire five years after such effective date, and have an exercise price of $[_____]
([_]% of the public offering price of the Units). Please see “Underwriting—Representative’s Warrants” for a description
of the warrants we have agreed to issue to the Representative in this offering, subject to the completion of the offering. We expect to
enter into a warrant agreement in respect of the Representative’s Warrants prior to the closing of this offering.

Effects of Certain Provisions of Our Articles of Incorporation and
Amended By-laws

Provisions of our articles
of incorporation, as amended, and our amended by-laws may delay or discourage transactions involving an actual or potential change of
control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares,
or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely
affect the price of our common stock.

Board of Directors; Removal
of Directors. The Board of Directors shall consist of one to nine persons. Increases or decreases to said number may be made, within
the numbers authorized by the Articles of Incorporation, as the Board of Directors shall from time to time determine by amendment to our
Bylaws. An increase or a decrease in the number of the members of the Board of Directors may also be had upon amendment to our Bylaws
by a majority vote of all of the shareholders, and the number of directors to be so increased or decreased shall be fixed upon a majority
vote of all of the shareholders of the corporation. Each director shall hold office until the next annual meeting of shareholders of the
corporation and until his or her successor shall have been elected and shall have qualified. Directors need not be residents of the state
of incorporation or shareholders of the corporation. At a meeting expressly called for that purpose, one or more directors may be removed
by a vote of a majority of the shares of outstanding stock of the corporation entitled to vote at an election of directors.

Board Vacancies.  If
any vacancies shall occur in the Board of Directors by reason of death, resignation or otherwise, or if the number of directors shall
be increased, the directors then in office shall continue to act and such vacancies or newly created directorships shall be filled by
a vote of the directors then in office, though less than a quorum, in any way approved by the meeting. Any directorship to be filled by
reason of removal of one or more directors by the shareholders may be filled by election by the shareholders at the meeting at which the
director or directors are removed.

Special Meetings of Stockholders.
Special meetings of the Board of Directors may be called by or at the request of the president, vice president, or any two directors.
The person or persons authorized to call special meetings of the Board of Directors may fix any place, either within or without the state
of incorporation, as the place for holding any special meeting of the Board of Directors called by them.

Blank-Check Preferred Stock.
Our board of directors will be authorized to issue, without stockholder approval, preferred stock, the rights of which will be determined
at the discretion of the board of directors and that, if issued, could operate as a “poison pill” to dilute the stock ownership
of a potential hostile acquirer to prevent an acquisition that our board of directors does not approve.

Nevada Anti-Takeover Statutes

The following provisions of
the Nevada Revised Statutes (“NRS”) could, if applicable, have the effect of discouraging takeovers of our company.

Transactions with Interested
Stockholders. The NRS prohibits a publicly-traded Nevada company from engaging in any business combination with an interested stockholder
for a period of three years following the date that the stockholder became an interested stockholder unless, prior to that date, the board
of directors of the corporation approved either the business combination itself or the transaction that resulted in the stockholder becoming
an interested stockholder.

An “interested stockholder”
is defined as any entity or person beneficially owning, directly or indirectly, 10% or more of the outstanding voting stock of the corporation
and any entity or person affiliated with, controlling, or controlled by any of these entities or persons. The definition of “business
combination” is sufficiently broad to cover virtually any type of transaction that would allow a potential acquirer to use the corporation’s
assets to finance the acquisition or otherwise benefit its own interests rather than the interests of the corporation and its stockholders.

In addition, business combinations
that are not approved and therefore take place after the three year waiting period may also be prohibited unless approved by the board
of directors and stockholders or the price to be paid by the interested stockholder is equal to the highest of (i) the highest price per
share paid by the interested stockholder within the 3 years immediately preceding the date of the announcement of the business combination
or in the transaction in which he or she became an interested stockholder, whichever is higher; (ii) the market value per common share
on the date of announcement of the business combination or the date the interested stockholder acquired the shares, whichever is higher;
or (iii) if higher for the holders of preferred stock, the highest liquidation value of the preferred stock.